INTRODUCCIÓN: REVISIÓN CRITICA DEL PROBLEMA

CAPÍTULO VIII
18. Murdoch DR, Love MP, Robb SD, McDonagh TA, Davie AP, Ford I, Capewell S, Morrison
CE, McMurray JJ. Importance of heart failure as a cause of death. Changing contribution
to overall mortality and coronary heart disease mortality in Scotland 1979–1992. Eur
Heart J. 1998 Dec;19(12):1829-35.
19. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in
prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med.
2006 Jul 20;355(3):251-9.
20. Aronow WS.Epidemiology, pathophysiology, prognosis, and treatment of systolic and
diastolic heart failure. Cardiol Rev. 2006 May-Jun;14(3):108-24.
21. Lee DS, Gona P, Vasan RS, Larson MG, Benjamin EJ, Wang TJ, Tu JV, Levy D. Relation of
disease pathogenesis and risk factors to heart failure with preserved or reduced ejection
fraction: insights from the framingham heart study of the national heart, lung, and blood
institute. Circulation. 2009 Jun 23;119(24):3070-7.
22. Fox KF, Cowie MR, Wood DA, Coats AJ, Gibbs JS, Underwood SR. Coronary artery disease
as the cause of incident heart failure in the population. Eur Heart J. 2001 Feb;22(3):228-
36.
23. Stewart S, Jenkins A, Buchan S, McGuire A, Capewell S, McMurray JJ.The current cost of
heart failure to the National Health Service in the UK. Eur J Heart Fail. 2002
Jun;4(3):361-71
24. Senni M, Tribouilloy CM, Rodeheffer RJ, Jacobsen SJ, Evans JM, Bailey KR, Redfield MM.
Congestive heart failure in the community: trends in incidence and survival in a 10-year
period. Arch Intern Med. 1999 Jan 11;159(1):29-34.
25. Blackledge HM, Tomlinson J, Squire IB. Prognosis for patients newly admitted to hospital
with heart failure: survival trends in 12 220 index admissions in Leicestershire 1993–
2001. Heart. 2003 Jun;89(6):615-20.
26. MacIntyre K, Capewell S, Stewart S, Chalmers JW, Boyd J, Finlayson A, Redpath A, Pell JP,
McMurray JJ. Evidence of improving prognosis in heart failure: trends in case fatality in
66 547 patients hospitalized between 1986 and 1995. Circulation. 2000 Sep
5;102(10):1126-31.
27. Schaufelberger M, Swedberg K, Koster M, Rosen M, Rosengren A. Decreasing one-year
mortality and hospitalization rates for heart failure in Sweden; data from the Swedish
Hospital Discharge Registry 1988 to 2000. Eur Heart J. 2004 Feb;25(4):300-7.
28. Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, Gong Y, Liu PP. Outcomeof heart
failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006
Jul 20;355(3):260-9.
29. Mann DL. Mechanisms and models in heart failure: A combinatorial approach. Circulation.
1999 Aug 31;100(9):999-1008.
30. Hasking GJ, Esler MD, Jennings GL, Burton D, Korner PI. Norepinephrine spillover to
plasma in patients with congestive heart failure: evidence of increased overall and
cardiorenal sympathetic nervous activity. Circulation. 1986;73:615– 621.
31. Mann DL. Basic mechanisms of disease progression in the failing heart: the role of
excessive adrenergic drive. Prog Cardiovasc Dis. 1998 Jul-Aug;41(1 Suppl 1):1-8.
32. Mann DL, Bristow MR. Mechanisms and models in heart failure: the biomechanical model
and beyond. Circulation. 2005 May 31;111(21):2837-49.
33. Cerqueira-Gomes M.Pathogenesis of heart failure--2000.Rev Port Cardiol. 2000
May;19(5):523-9.
34. Kane GC, Karon BL, Mahoney DW, Redfield MM, Roger VL, Burnett JC Jr, Jacobsen SJ,
Rodeheffer RJ. Progression of left ventricular diastolic dysfunction and risk of heart
failure. JAMA. 2011 Aug 24;306(8):856-63.
35. Dhalla NS, Saini-Chohan HK, Rodriguez-Leyva D, Elimban V, Dent MR, Tappia PS.
Subcellular remodelling may induce cardiac dysfunction in congestive heart failure.
Cardiovasc Res. 2009 Feb 15;81(3):429-38. Epub 2008 Oct 13.
226